Menu Search
Equities

Global Hemp Group Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
GHG0:FRA

Global Hemp Group Inc

Actions
  • Price (EUR)0.011
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-38.89%
  • Beta2.0941
Data delayed at least 15 minutes, as of Apr 16 2025 07:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Global Hemp Group Inc. is a Canada-based company. The Company is focused on two business segments: Industrial Hemp and Health & Wellness (Biopharma). The Industrial Hemp segment primary focus lies in the environmental uses of hemp for construction and hemp for sustainable bio-energy sources, both contributing to a carbon-negative footprint. It is also focused on aligning with its hemp agro-industrial zone (HAIZ) strategy to achieve a carbon-negative footprint. Its principal feature of the HAIZ concept is the proximity of the industrial plant to the supply of raw materials and final markets. The Health and Wellness segment is focused on the acquisition of exclusive licensing of patents and intellectual property (IP). It acquired exclusive rights to key patents and IP of Apollon Formularies plc., a UK-based international pharmaceutical company whose formulations and patents specialize in developing cancer treatments from natural biologics, including cannabinoids and functional mushrooms.

  • Revenue in CAD (TTM)0.00
  • Net income in CAD-2.94m
  • Incorporated2009
  • Employees--
  • Location
    Global Hemp Group Inc#106 - 1169 Mt. Seymour RoadNORTH VANCOUVER V7H 2Y4CanadaCAN
  • Phone+1 (778) 726-2900
  • Websitehttps://globalhempgroup.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.